Company Performance Metrics
Foment Bio is a clinical-stage biotechnology company developing non-viral, off-the-shelf, gene-based products that activate natural healing cascades to repair tissue and restore organ function. Its pipeline consists of products that drive transient in vivo production of regenerative exosomes able to promote new blood vessel growth, prevent cell
death, reduce scar formation, and resolve tissue inflammation.
This treatment approach captures the benefit of cell & exosome-based therapy while transferring the therapy production from a complex and expensive ex vivo process to an inexpensive, evolutionarily optimized in vivo process. Foment’s transient gene therapy constructs possess substantial benefits over alternative treatment modalities, including: a strong safety profile, efficient and scalable manufacturing, robust product stability, and repeat dosing.
